Literature DB >> 20927075

Hepatosplenic T-cell lymphoma in inflammatory bowel disease: a possible thiopurine-induced chromosomal abnormality.

David S Kotlyar, Wojciech Blonski, Robert H Diamond, Mariusz Wasik, Gary R Lichtenstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20927075     DOI： 10.1038/ajg.2010.213

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  8 in total

Review 1.  Remicade® (infliximab): 20 years of contributions to science and medicine.

Authors:  Richard Melsheimer; Anja Geldhof; Isabel Apaolaza; Thomas Schaible
Journal:  Biologics       Date:  2019-07-30

2.  Seroprevalence of Epstein-Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel Disease.

Authors:  Ondrej Hradsky; Ivana Copova; Kristyna Zarubova; Marianna Durilova; Jiri Nevoral; Miroslav Maminak; Petr Hubacek; Jiri Bronsky
Journal:  Dig Dis Sci       Date:  2015-06-20       Impact factor: 3.199

Review 3.  Immunomodulatory Agents for Treatment of Patients with Inflammatory Bowel Disease (Review safety of anti-TNF, Anti-Integrin, Anti IL-12/23, JAK Inhibition, Sphingosine 1-Phosphate Receptor Modulator, Azathioprine / 6-MP and Methotrexate).

Authors:  Lindsey Sattler; Stephen B Hanauer; Lisa Malter
Journal:  Curr Gastroenterol Rep       Date:  2021-12-16

4.  Primary effusion lymphoma-like lymphoma in a patient with inflammatory bowel disease.

Authors:  Elchanan Nussinson; Fahmi Shibli; Azmi Shahbari; Wasseem Rock; Mazen Elias; Irit Elmalah
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

Review 5.  Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease.

Authors:  Parambir S Dulai; Corey A Siegel; Marla C Dubinsky
Journal:  Inflamm Bowel Dis       Date:  2013-12       Impact factor: 5.325

6.  Use of case reports and the Adverse Event Reporting System in systematic reviews: overcoming barriers to assess the link between Crohn's disease medications and hepatosplenic T-cell lymphoma.

Authors:  Saranya A Selvaraj; Elizabeth Chairez; Lisa M Wilson; Mark Lazarev; Eric B Bass; Susan Hutfless
Journal:  Syst Rev       Date:  2013-07-05

7.  Hepatosplenic T-cell lymphoma in a 47-year-old Crohn's disease patient on thiopurine monotherapy.

Authors:  Maartje M van de Meeberg; Lauranne A A P Derikx; Harm A M Sinnige; Peet Nooijen; D Lucette Schipper; Loes H C Nissen
Journal:  World J Gastroenterol       Date:  2016-12-21       Impact factor: 5.742

Review 8.  Recent advances in understanding and managing pediatric inflammatory bowel disease.

Authors:  Bhaskar Gurram; Ashish S Patel
Journal:  F1000Res       Date:  2019-12-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.